Court Sends DictateMD Trade Secret Claims to Arbitration
A federal judge in St. Louis ruled that DictateMD's claims against former Eli Health CEO Ali Ahmadi must proceed in arbitration.
Updated on Nov. 3, 2026 in Healthcare
The U.S. District Court for the Eastern District of Missouri granted Ali Ahmadi's motion to compel arbitration in a trade secret dispute brought by DictateMD, Inc. On October 15, 2026, the court ruled the claims are arbitrable and did not consider Ahmadi's motion to dismiss.
Why it matters
The ruling moves DictateMD's allegations that a former executive misappropriated its healthcare administration platform out of open court and into a private forum. For St. Louis-area healthcare technology firms, it underscores how confidentiality and arbitration clauses in vendor agreements can determine where disputes are resolved.
DictateMD says it invested at least $2 million over 18 months building its Medicare and Medicaid administration platform. The court's ruling resolves only where the claims will be heard, not whether Ahmadi misappropriated any trade secrets.
The players
DictateMD, Inc.
A healthcare technology company that developed a platform enabling organizations to administer Medicare and Medicaid programs, and which brought the trade secret suit.
Ali Ahmadi
Former chief executive officer of Eli Health who executed the confidentiality agreements at issue and is the defendant seeking arbitration.
ADR Services, Inc.
An alternative dispute resolution provider whose rules are incorporated into the agreements, governing how the arbitration will proceed.
The details
DictateMD alleges Ahmadi, former CEO of Eli Health, signed confidentiality agreements containing anti-reverse-engineering provisions and then orchestrated a scheme to misappropriate the platform to build a competing product. The court held the claims arise from and are intertwined with the Billing Services Agreement and Dementia Care Support Services Agreement, both of which incorporate ADR Services, Inc. arbitration rules.
Timeline
October 15, 2026: The court ruled DictateMD's claims against Ahmadi are arbitrable.
November 3, 2026: Reporting on the arbitrability ruling was published.
Market Landscape
Courts have consistently enforced arbitration clauses in commercial contracts under the Federal Arbitration Act, which steers contract-based tech disputes away from public litigation. The ruling reinforces that vendor and partner agreements in healthcare technology are a primary venue for shaping where competitive disputes are resolved.
Companies that share proprietary platforms with partners should review confidentiality and arbitration terms, since those clauses determine where disputes are heard. Employees and contractors who sign such agreements may face arbitration rather than court proceedings if a dispute arises.
The takeaway
Contract language signed during a business relationship can decide the forum for later disputes, so the terms governing confidentiality and arbitration deserve close attention before a deal is signed.
Further reading
Explore more Healthcare coverage from St. Louis.
Source note: This article includes information reported by Missouri Lawyers Media.
